These findings provide the first evidence of the molecular mechanisms of MLL1, which nucleates histone H3K4 methylation marks at CpG islands to maintain chromatin accessibility for binding of ERα and its pioneer factor FOXA1 in breast cancer cells. This evidence concerns the gene FOXA1 and breast carcinoma.